Clinical Trials Logo
  1. Home
  2. Hypertension
  3. NCT06291207
  4. Details
NCT06291207 Clinical Trial

A Study to Evaluate the Efficacy and Safety of AD-224

Hypertension,Essential Clinical Trial

Official title:
A Randomization, Double-blind, Active-controlled, Multicenter, Phase 3 Trial to Evaluate the Efficacy and Safety of AD-224A and AD-224B in Patients With Essential Hypertension

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT06291207
Other study ID # AD-224P3
Secondary ID
Status Not yet recruiting
Phase Phase 3
First received
Last updated
Start date April 2024
Est. completion date December 2024

Study information
Verified date February 2024
Source Addpharma Inc.
Contact JeongEun Park
Phone +82-31-891-6989
Email parkje@addpharma.co.kr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy and safety of AD-224

Description:

Condition or disease : Essential Hypertension

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 252
Est. completion date December 2024
Est. primary completion date December 2024
Accepts healthy volunteers No
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria: - Signed informed consent - Patients with Essential Hypertension - Other inclusions applied Exclusion Criteria: - Patient with Secondary Hypertension - Other exclusions applied

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• AD-224A
PO, Once daily, 8weeks
• AD-224B
PO, Once daily, 8weeks
• AD-224C
PO, Once daily, 8weeks
• Placebo of AD-224A
PO, Once daily, 8weeks
• Placebo of AD-224B
PO, Once daily, 8weeks
• Placebo of AD-224C
PO, Once daily, 8weeks

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Addpharma Inc.

Outcome
Type Measure Description Time frame Safety issue
Primary Change rate of MSSBP Change from baseline in mean sitting systolic blood pressure Baseline, Week 8
See also
  Status Clinical Trial Phase
Recruiting NCT05546931 - Mobile Health Program for Rural Hypertension N/A
Completed NCT05086549 - An Observation Study to Evaluate the Renoprotective Effect of Fimasartan in Patients With DKD and Proteinuria
Recruiting NCT05086523 - Cardiac Neuromodulation Therapy (CNT) "Washout" Sub-Study Phase 1/Phase 2
Active, not recruiting NCT03503773 - The TARGET BP OFF-MED Trial Phase 2
Not yet recruiting NCT04082091 - Screening, Early Referral and Lifestyle Tailored E_prescription for Cardiovascular Prevention
Recruiting NCT06019598 - Licorice and Home Blood Pressure, Additional Study N/A
Completed NCT04495231 - Sympathetic Activity and Cardiometabolic Complications
Completed NCT04119999 - A Cardiosleep Research Program on Obstructive Sleep Apnea, Blood Pressure Control and Maladaptive Myocardial Remodeling N/A
Recruiting NCT04505618 - Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease N/A
Recruiting NCT04863508 - Wearable Blood Pressure Devices to Identify Masked Uncontrolled Hypertension.
Completed NCT05185297 - Recreational Futsal for Controlled Hypertension N/A
Completed NCT03855605 - Diagnosis of Hypertension by Home Blood Pressure Monitoring
Completed NCT03901183 - Plant-based Nutrition for Patients With Cardiovascular Risk Factors N/A
Recruiting NCT03206814 - Improving Hypertension Control in CHina and ARGEntina With a Mobile APP-based Telecare System N/A
Recruiting NCT06343246 - Functional Inspiratory Muscle Training in Patients Diagnosed With Hypertension N/A
Completed NCT06359873 - Left Atrial Enlargement: A Crucial Indicator for Identifying Atrial Fibrillation in Patients With Hypertension
Recruiting NCT04565548 - Hypertension Treatment Adherence Improving Trial N/A
Recruiting NCT06205628 - Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension Phase 1
Recruiting NCT06052748 - A Study to Evaluate the Efficacy and Safety of AD-223 Phase 3
Recruiting NCT04613193 - Blood Pressure Reduction in Patients With Asymptomatic Aortic VALVE Stenosis N/A